{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:57:37Z","timestamp":1795089457213,"version":"4.10.2"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41591-018-0005-y","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T04:32:36Z","timestamp":1523853156000},"page":"667-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss"],"prefix":"10.1038","volume":"24","author":[{"given":"Sarah","family":"Weske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithila","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"von Wnuck Lipinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Keul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens W","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Fl\u00f6gel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Nelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Epple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edzard","family":"Schwedhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-5449","authenticated-orcid":false,"given":"Anke","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard H","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus H","family":"Gr\u00e4ler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Levkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka, M., Harikumar, K. B., Milstien, S. & Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22, 50\u201360 (2012).","journal-title":"Trends Cell Biol"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/pr.107.07113","volume":"60","author":"K Takabe","year":"2008","unstructured":"Takabe, K., Paugh, S. W., Milstien, S. & Spiegel, S. \u201cInside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60, 181\u2013195 (2008).","journal-title":"Pharmacol. Rev."},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","volume":"82","author":"H Rosen","year":"2013","unstructured":"Rosen, H., Stevens, R. C., Hanson, M., Roberts, E. & Oldstone, M. B. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu. Rev. Biochem. 82, 637\u2013662 (2013).","journal-title":"Annu. Rev. Biochem."},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel, G. T., Maceyka, M., Milstien, S. & Spiegel, S. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat. Rev. Drug Discov. 12, 688\u2013702 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum, S. L. Bone resorption by osteoclasts. Science 289, 1504\u20131508 (2000).","journal-title":"Science"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbalip.2012.06.002","volume":"1831","author":"M Ishii","year":"2013","unstructured":"Ishii, M. & Kikuta, J. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim. Biophys. Acta 1831, 223\u2013227 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"5_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6215","volume":"5","author":"J Keller","year":"2014","unstructured":"Keller, J. et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. Nat. Commun. 5, 5215 (2014).","journal-title":"Nat. Commun."},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","volume":"25","author":"J Ryu","year":"2006","unstructured":"Ryu, J. et al. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 25, 5840\u20135851 (2006).","journal-title":"EMBO J."},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1084\/jem.20101474","volume":"207","author":"M Ishii","year":"2010","unstructured":"Ishii, M., Kikuta, J., Shimazu, Y., Meier-Schellersheim, M. & Germain, R. N. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J. Exp. Med. 207, 2793\u20132798 (2010).","journal-title":"J. Exp. Med."},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10059-011-1010-x","volume":"31","author":"T Ishii","year":"2011","unstructured":"Ishii, T., Shimazu, Y., Nishiyama, I., Kikuta, J. & Ishii, M. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. Mol. Cells 31, 399\u2013403 (2011).","journal-title":"Mol. Cells"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"20764","DOI":"10.1073\/pnas.0805133106","volume":"105","author":"L Pederson","year":"2008","unstructured":"Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S. & Oursler, M. J. Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA 105, 20764\u201320769 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5_CR12","first-page":"666","volume":"123","author":"S Lotinun","year":"2013","unstructured":"Lotinun, S. et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Invest. 123, 666\u2013681 (2013).","journal-title":"J. Clin. Invest."},{"key":"5_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004112","volume":"4","author":"P Vogel","year":"2009","unstructured":"Vogel, P. et al. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One 4, e4112 (2009).","journal-title":"PLoS One"},{"key":"5_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059630","volume":"8","author":"A Billich","year":"2013","unstructured":"Billich, A. et al. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis. PLoS One 8, e59630 (2013).","journal-title":"PLoS One"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMct1101691","volume":"366","author":"D Pelletier","year":"2012","unstructured":"Pelletier, D. & Hafler, D. A. Fingolimod for multiple sclerosis. N. Engl. J. Med. 366, 339\u2013347 (2012).","journal-title":"N. Engl. J. Med."},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla, S. Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142, 5050\u20135055 (2001).","journal-title":"Endocrinology"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cmet.2005.11.011","volume":"2","author":"BF Boyce","year":"2005","unstructured":"Boyce, B. F., Xing, L. & Chen, D. Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling. Cell Metab. 2, 344\u2013345 (2005).","journal-title":"Cell Metab."},{"key":"5_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-2-11","volume":"2","author":"N Yokoyama","year":"2007","unstructured":"Yokoyama, N., Yin, D. & Malbon, C. C. Abundance, complexation, and trafficking of Wnt\/beta-catenin signaling elements in response to Wnt3a. J. Mol. Signal 2, 11 (2007).","journal-title":"J. Mol. Signal"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1242\/jcs.032854","volume":"121","author":"RK Bikkavilli","year":"2008","unstructured":"Bikkavilli, R. K., Feigin, M. E. & Malbon, C. C. p38 mitogen-activated protein kinase regulates canonical Wnt-\u03b2-catenin signaling by inactivation of GSK3\u03b2. J. Cell Sci. 121, 3598\u20133607 (2008).","journal-title":"J. Cell Sci."},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1242\/jcs.02883","volume":"119","author":"GJ Spencer","year":"2006","unstructured":"Spencer, G. J., Utting, J. C., Etheridge, S. L., Arnett, T. R. & Genever, P. G. Wnt signalling in osteoblasts regulates expression of the receptor activator of NF\u03ba ligand and inhibits osteoclastogenesis in vitro. J. Cell Sci. 119, 1283\u20131296 (2006).","journal-title":"J. Cell Sci."},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","volume":"247","author":"A Mizuno","year":"1998","unstructured":"Mizuno, A. et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin. Biochem. Biophys. Res. Commun. 247, 610\u2013615 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143\u2013147 (1999).","journal-title":"Science"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"12532","DOI":"10.1073\/pnas.211416898","volume":"98","author":"HG Linhart","year":"2001","unstructured":"Linhart, H. G. et al. C\/EBP\u03b1 is required for differentiation of white, but not brown, adipose tissue. Proc. Natl. Acad. Sci. USA 98, 12532\u201312537 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"14515","DOI":"10.1074\/jbc.M700030200","volume":"282","author":"S Kang","year":"2007","unstructured":"Kang, S. et al. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT\/enhancer-binding protein \u03b1 and peroxisome proliferator-activated receptor \u03b3. J. Biol. Chem. 282, 14515\u201314524 (2007).","journal-title":"J. Biol. Chem."},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biocel.2011.11.013","volume":"44","author":"WH Yu","year":"2012","unstructured":"Yu, W. H. et al. PPAR\u03b3 suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells. Int. J. Biochem. Cell Biol. 44, 377\u2013384 (2012).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/jbmr.1694","volume":"27","author":"L Song","year":"2012","unstructured":"Song, L. et al. Loss of wnt\/beta-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes. J. Bone Miner. Res. 27, 2344\u20132358 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"5_CR27","first-page":"193","volume":"1","author":"WS Jee","year":"2001","unstructured":"Jee, W. S. & Yao, W. Overview: animal models of osteopenia and osteoporosis. J. Musculoskelet. Neuronal Interact. 1, 193\u2013207 (2001).","journal-title":"J. Musculoskelet. Neuronal Interact"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1210\/jc.2003-030242","volume":"88","author":"MC Carr","year":"2003","unstructured":"Carr, M. C. The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 88, 2404\u20132411 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00394-011-0266-4","volume":"51","author":"RE Stubbins","year":"2012","unstructured":"Stubbins, R. E., Holcomb, V. B., Hong, J. & N\u00fa\u00f1ez, N. P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur. J. Nutr. 51, 861\u2013870 (2012).","journal-title":"Eur. J. Nutr."},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyp394","volume":"40","author":"H V\u00f6lzke","year":"2011","unstructured":"V\u00f6lzke, H. et al. Cohort profile: the study of health in Pomerania. Int. J. Epidemiol. 40, 294\u2013307 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0140-6736(95)11456-4","volume":"348","author":"D Hans","year":"1996","unstructured":"Hans, D. et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348, 511\u2013514 (1996).","journal-title":"Lancet"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman, F. et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos. Int. 25, 2359\u20132381 (2014).","journal-title":"Osteoporos. Int."},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright, N. C. et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J. Bone Miner. Res. 29, 2520\u20132526 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bone.2016.12.012","volume":"96","author":"MR McClung","year":"2017","unstructured":"McClung, M. R. Clinical utility of anti-sclerostin antibodies. Bone 96, 3\u20137 (2017).","journal-title":"Bone"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. & Karsenty, G. Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747\u2013754 (1997).","journal-title":"Cell"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1101\/gad.948702","volume":"16","author":"ED Rosen","year":"2002","unstructured":"Rosen, E. D. et al. C\/EBP\u03b1 induces adipogenesis through PPAR\u03b3: a unified pathway. Genes Dev. 16, 22\u201326 (2002).","journal-title":"Genes Dev"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1749-799X-5-37","volume":"5","author":"C Zhang","year":"2010","unstructured":"Zhang, C. Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J. Orthop. Surg. Res. 5, 37 (2010).","journal-title":"J. Orthop. Surg. Res"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/107632701753337681","volume":"7","author":"YD Halvorsen","year":"2001","unstructured":"Halvorsen, Y. D. et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 7, 729\u2013741 (2001).","journal-title":"Tissue Eng."},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00223-011-9461-9","volume":"88","author":"T Takahashi","year":"2011","unstructured":"Takahashi, T. Overexpression of Runx2 and MKP-1 stimulates transdifferentiation of 3T3-L1 preadipocytes into bone-forming osteoblasts in vitro. Calcif. Tissue Int. 88, 336\u2013347 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11010-006-9399-9","volume":"301","author":"L Wu","year":"2007","unstructured":"Wu, L. et al. Osteogenic differentiation of adipose derived stem cells promoted by overexpression of osterix. Mol. Cell. Biochem. 301, 83\u201392 (2007).","journal-title":"Mol. Cell. Biochem."},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.bbrc.2004.12.076","volume":"327","author":"SW Kim","year":"2005","unstructured":"Kim, S. W., Her, S. J., Kim, S. Y. & Shin, C. S. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem. Biophys. Res. Commun. 327, 811\u2013819 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","volume":"74","author":"B Lecka-Czernik","year":"1999","unstructured":"Lecka-Czernik, B. et al. Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPAR\u03b32. J. Cell. Biochem. 74, 357\u2013371 (1999).","journal-title":"J. Cell. Biochem."},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj20030426","volume":"376","author":"M Moldes","year":"2003","unstructured":"Moldes, M. et al. Peroxisome-proliferator-activated receptor \u03b3 suppresses Wnt\/\u03b2-catenin signalling during adipogenesis. Biochem. J. 376, 607\u2013613 (2003).","journal-title":"Biochem. J."},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(00)80306-8","volume":"3","author":"Z Wu","year":"1999","unstructured":"Wu, Z. et al. Cross-regulation of C\/EBP \u03b1 and PPAR \u03b3 controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3, 151\u2013158 (1999).","journal-title":"Mol. Cell"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur, T. et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280, 33132\u201333140 (2005).","journal-title":"J. Biol. Chem."},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/ncb1107-1229","volume":"9","author":"T G\u00fcnther","year":"2007","unstructured":"G\u00fcnther, T. & Sch\u00fcle, R. Fat or bone? A non-canonical decision. Nat. Cell Biol. 9, 1229\u20131231 (2007).","journal-title":"Nat. Cell Biol."},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/ncb1647","volume":"9","author":"I Takada","year":"2007","unstructured":"Zioco, E. et al. Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment. Oncotarget\u00a07, 20223\u201320235 (2016).","journal-title":"Nat. Cell Biol."},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1210\/en.2004-0735","volume":"146","author":"AA Ali","year":"2005","unstructured":"Ali, A. A. et al. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146, 1226\u20131235 (2005).","journal-title":"Endocrinology"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jcb.21994","volume":"106","author":"KR Shockley","year":"2009","unstructured":"Shockley, K. R. et al. PPAR\u03b32 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J. Cell. Biochem. 106, 232\u2013246 (2009).","journal-title":"J. Cell. Biochem."},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-014-2290-1","volume":"401","author":"Y Hashimoto","year":"2015","unstructured":"Hashimoto, Y. et al. Sphingosine-1-phosphate inhibits differentiation of C3H10T1\/2 cells into adipocyte. Mol. Cell. Biochem. 401, 39\u201347 (2015).","journal-title":"Mol. Cell. Biochem."},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1096\/fj.06-6624hyp","volume":"21","author":"EJ Goetzl","year":"2007","unstructured":"Goetzl, E. J. Diverse pathways for nuclear signaling by G protein\u2013coupled receptors and their ligands. FASEB J. 21, 638\u2013642 (2007).","journal-title":"FASEB J."},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1096\/fj.14-261289","volume":"29","author":"KA Parham","year":"2015","unstructured":"Parham, K. A. et al. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-gamma that regulates neoangiogenesis. FASEB J. 29, 3638\u20133653 (2015).","journal-title":"FASEB J."},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1097\/01.prs.0000206319.80719.74","volume":"117","author":"IA Peptan","year":"2006","unstructured":"Peptan, I. A., Hong, L. & Mao, J. J. Comparison of osteogenic potentials of visceral and subcutaneous adipose-derived cells of rabbits. Plast. Reconstr. Surg. 117, 1462\u20131470 (2006).","journal-title":"Plast. Reconstr. Surg."},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nature06902","volume":"453","author":"KL Spalding","year":"2008","unstructured":"Spalding, K. L. et al. Dynamics of fat cell turnover in humans. Nature 453, 783\u2013787 (2008).","journal-title":"Nature"},{"key":"5_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072449","volume":"8","author":"GM Kowalski","year":"2013","unstructured":"Kowalski, G. M., Carey, A. L., Selathurai, A., Kingwell, B. A. & Bruce, C. R. Plasma sphingosine-1-phosphate is elevated in obesity. PLoS One 8, e72449 (2013).","journal-title":"PLoS One"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"E1421","DOI":"10.1210\/jc.2012-1044","volume":"97","author":"SH Lee","year":"2012","unstructured":"Lee, S. H. et al. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. J. Clin. Endocrinol. Metab. 97, E1421\u2013E1428 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00198-016-3565-z","volume":"27","author":"SJ Bae","year":"2016","unstructured":"Bae, S.J. et al. The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal woman: a 3.5-year follow-up observation study. Osteoporos. Int. 27, 2533-2541 (2016).","journal-title":"Osteoporos. Int."},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nm.2617","volume":"18","author":"G Zhang","year":"2012","unstructured":"Zhang, G. et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat. Med. 18, 307\u2013314 (2012).","journal-title":"Nat. Med"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791","volume":"21","author":"C Liang","year":"2015","unstructured":"Liang, C. et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nat. Med 21, 288\u2013294 (2015).","journal-title":"Nat. Med"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1359\/jbmr.070813","volume":"23","author":"LJ Zhao","year":"2008","unstructured":"Zhao, L. J. et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Miner. Res. 23, 17\u201329 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.1113640","volume":"309","author":"SR Schwab","year":"2005","unstructured":"Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735\u20131739 (2005).","journal-title":"Science"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468\u20131486 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-62703-989-5_11","volume":"1130","author":"T Kawamoto","year":"2014","unstructured":"Kawamoto, T. & Kawamoto, K. Preparation of thin frozen sections from nonfixed and undecalcified hard tissues using Kawamot's film method (2012). Methods Mol. Biol. 1130, 149\u2013164 (2014).","journal-title":"Methods Mol. Biol"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/002215540205000305","volume":"50","author":"D Miao","year":"2002","unstructured":"Miao, D. & Scutt, A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J. Histochem. Cytochem. 50, 333\u2013340 (2002).","journal-title":"J. Histochem. Cytochem."},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2\u201317 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0142-9612(03)00580-5","volume":"25","author":"H Declercq","year":"2004","unstructured":"Declercq, H. et al. Isolation, proliferation and differentiation of osteoblastic cells to study cell\/biomaterial interactions: comparison of different isolation techniques and source. Biomaterials 25, 757\u2013768 (2004).","journal-title":"Biomaterials"},{"issue":"7495","key":"5_CR67","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","volume":"508","author":"Daniel Kraus","year":"2014","unstructured":"Kraus, D. et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508,\u00a0258\u2013262 (2014).","journal-title":"Nature"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/0970-0218.42051","volume":"33","author":"K A","year":"2008","unstructured":"Kumar, A. et al. Profile of clients tested HIV positive in a voluntary counseling and testing center of a district hospital, Udupi, South Kannada. Indian J. Community Med. 33, 156\u2013159 (2008).","journal-title":"Indian J. Community Med."},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/13813455.2012.755547","volume":"119","author":"S Burghoff","year":"2013","unstructured":"Burghoff, S. et al. Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice. Arch. Physiol. Biochem. 119, 39\u201351 (2013).","journal-title":"Arch. Physiol. Biochem."},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3945\/ajcn.111.012948","volume":"94","author":"S Tucci","year":"2011","unstructured":"Tucci, S., Fl\u00f6gel, U., Sturm, M., Borsch, E. & Spiekerkoetter, U. Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a beta-oxidation defect. Am. J. Clin. Nutr. 94, 439\u2013449 (2011).","journal-title":"Am. J. Clin. Nutr"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cca.2017.01.029","volume":"468","author":"E Moritz","year":"2017","unstructured":"Moritz, E. et al. Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania. Clin. Chim. Acta 468, 25\u201331 (2017).","journal-title":"Clin. Chim. Acta"},{"key":"5_CR72","first-page":"365","volume":"112","author":"C Sch\u00fcrer","year":"2015","unstructured":"Sch\u00fcrer, C. et al. Fracture risk and risk factors for osteoporosis. Dtsch. Arztebl. Int. 112, 365\u2013371 (2015).","journal-title":"Dtsch. Arztebl. Int."},{"key":"5_CR73","first-page":"45","volume-title":"Statistical Computing Section, Proceedings of the American Statistical Association.","author":"CJ Stone","year":"1985","unstructured":"Stone, C. J. & Koo, C. Y. Additive splines in statistics. in Statistical Computing Section, Proceedings of the American Statistical Association 45\u201348 (American Statistical Association, Washington, DC, 1985)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0005-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:55:49Z","timestamp":1684605349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0005-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733068875.793546205","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"11 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}